Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2000

View Archived Issues

Pharmacopeia achieves milestone in Schering collaboration

M.D. Anderson Cancer Center to guide arglabin preclinical studies

Partners lay the groundwork to begin clinical testing of novel anti-HCV agent

ISIS-5132 reduces target RNA levels in human study

DiagnoCure submits new file to support approval of ImmunoCyt

Progenics and ADARC advance HIV vaccine research

Avant Immunotherapeutics updates progress with CETi-1

SuperGen licenses VTA technology from Techniclone

Sangamo and Baxter to collaborate on novel vascular disease therapeutics

Protein Design Labs and Celltech Chiroscience enter antibody patent agreement

Patent and orphan drug status obtained for Inhale's alpha1-proteinase inhibitor

The Liposome Company submits additional Evacet data to FDA

New antiinflammatory agents from HMR (Aventis) act by inhibiting cell adhesion

Discovery and use of E6-binding polypeptides for suppressing tumor growth

Clomethiazole: use in spinal cord injury

Agonists and antagonists of orphanin FQ receptor prepared by Roche

Modifications of carbapenem nucleus an important area of research at Merck

Aryl pyridinyl thiazoles from Novartis useful for inflammatory or obstructive airways diseases

Oxazolidinones in development at AstraZeneca useful against resistant Gram-positive pathogens

FDA issues public health advisory for influenza drugs

Trileptal granted FDA approval for treatment of epilepsy

EpiGenesis and Chiesi enter license and development agreement for asthma therapy

Patent coverage granted for Cell Genesys's third-generation lentiviral vectors

Broad patent issued to IntraBiotics covering its protegrin analogues

Promising preclinical results with StressGen's stress proteins published

Pre- and postischemic treatment with FR-183998 cardioprotective in rat models

Vivus and AstraZeneca resolve Muse distribution agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...